OXYGENATORS MARKET ANALYSIS

Oxygenators Market, By Product Type (Bubble Oxygenator and Membrane Oxygenator), By Application (Respiratory, Cardiac, and Extracorporeal Cardiopulmonary Resuscitation (ECPR)), and By Geography (North America, Europe, Asia Pacific, Latin America, and Middle East & Africa)

Published In : Mar 2023
Code : CMI5620
Pages :167
Formats :
Excel and PDF
Industry : Medical Devices

Market News

Global Oxygenators Market: Key Developments

In August 2020, Terumo Cardiovascular and CytoSorbents temped up to commercialize CytoSorb in Ten U.S. hotspot states under emergency use authorization for COVID-19. The product is useful for providing oxygen exchange in critically ill adults from COVID-19.

In June 2020, NuvOx Pharma received the approval from Health Canada to proceed with the Phase IIa clinical trial of NanO2 in COVID-19 subjects with acute hypoxic respiratory failure (AHRF) where NanO2 can act as a cardioprotectant.

In April 2020, Genrich Membranes developed membrane oxygenator equipment for the treatment of COVID-19 patients. With an urgent requirement of respiratory interventions to treat the critical symptoms of COVID-19, the equipment can be used to treat patients who have been released from Intensive Care Units (ICU).